Apple presents smartwatch results from 400,000-strong heart study
March 18, 2019
By Neozene

After canvassing more than 400,000 people across all 50 states in just eight months, Apple has finished a virtual investigation of its smartwatch’s ability to alert users to irregular heart rhythms possibly linked to atrial fibrillation. It was one of the largest studies of its kind. The Apple Heart Study—first launched in November 2017 in collaboration with Stanford Medicine—focuses on the earlier generations of the Apple Watch, which lack the latest version’s onboard ECG that was cleared by the FDA last fall. Instead, the smartwatches check a user’s pulse rate in

Read More

Trump’s budget plan puts squeeze on NIH, boosts FDA
March 12, 2019
By Neozene

President Trump’s budget proposals for 2020 are in, seeking a cut for the National Institutes of Health (NIH) for the third year in a row but an increase in the FDA’s finances. The plan is allocating $35.4 billion for the NIH—estimated to be somewhere between $4.5 and $6 billion less than in the current financial year—and is accompanied by other cuts including a $1 billion reduction for the National Science Foundation (NSF). Among the biggest losers within the NIH are the National Cancer Institute, which would see $900 million carved

Read More

New strategies for improving pancreatic cancer treatments
March 5, 2019
By Neozene

Pancreatic cancer is so difficult to treat that the one-year survival rate across all stages of diagnosis is just 20%. Two discoveries announced on Monday—one related to a new combination treatment and the other to genetic testing—could improve the prognosis for patients with pancreatic cancer. The potential new treatment strategy capitalizes on a natural process known as autophagy, in which cells recycle some of their own components to use as an energy source. Researchers at the University of North Carolina Lineberger Comprehensive Cancer Center figured out how to coax pancreatic cancer

Read More